Novel glucose-responsive nanoparticles based on p-hydroxyphenethyl anisate and 3-acrylamidophenylboronic acid reduce blood glucose and ameliorate diabetic nephropathy.

Ma, Qiong; Bian, Ligong; Zhao, Xi; Tian, Xuexia; Yin, Hang; Wang, Yutian; Shi, Anhua; Wu, Junzi

Ma, Qiong; Bian, Ligong; Zhao, Xi; Tian, Xuexia; Yin, Hang; Wang, Yutian; Shi, Anhua; Wu, Junzi.

Afiliação

Ma Q; The Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650500, PR China.
Bian L; Department of Medical Biology, College of Basic Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650500, PR China.
Zhao X; The Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650500, PR China.
Tian X; The Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650500, PR China.
Yin H; The Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650500, PR China.
Wang Y; The Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650500, PR China.
Shi A; The Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650500, PR China.
Wu J; The Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650500, PR China.

Mater Today Bio ; 13: 100181, 2022 Jan.

Article em En | MEDLINE | ID: mdl-34927045